Liraglutide 3 mg for Weight Loss in a Real-World Setting: Clinical Outcomes after 56 Weeks

被引：0
|
作者：
Buckley, Adam J.
Suliman, Mohamed
Al Tikriti, Alia
Lessan, Nader
Le Roux, Carel
Tan, Tricia M.
Barakat, Maha T.
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-2308-PUB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2308-PUB
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Liraglutide 3.0 mg (Saxenda©) for Weight Loss and Remission of Pre-Diabetes. Real-World Clinical Evaluation of Effectiveness among Patients Awaiting Bariatric Surgery
    Wilmington, Rebekah
    Ardavani, Arash
    Simenacz, Amelia
    Green, Carol
    Idris, Iskandar
    OBESITY SURGERY, 2024, 34 (01) : 286 - 289
  • [22] Response to "Liraglutide Effectiveness: Is There a Real-World Clinical Benefit?"
    Wharton, Sean
    Liu, Aiden
    Pakseresht, Arash
    Nortoft, Emil
    Haase, Christiane L.
    Mancini, Johanna
    Power, G. Sarah
    Vanderlelie, Sarah
    Christensen, Rebecca A. G.
    OBESITY, 2019, 27 (11) : 1728 - 1728
  • [23] Effectiveness and persistence of anti-obesity medications (liraglutide 3 mg, lorcaserin, and orlistat) in a real-world primary care setting
    Leventhal-Perek, Sharon
    Shani, Michal
    Schonmann, Yochai
    FAMILY PRACTICE, 2023, 40 (5-6) : 629 - 637
  • [24] Patterns of Care in Craniopharyngioma: Clinical Outcomes After Surgery and Radiation Therapy in a Real-World Setting
    Ghosh, Suman
    Goda, Jayant S.
    Chatterjee, Abhishek
    Shetty, Prakash
    Sahay, Ayushi
    Dasgupta, Archya
    Epari, Sridhar
    Sahu, Arpita
    Singh, Vikas
    Gupta, Tejpal
    Moyiadi, Ali Asgar
    Jalali, Rakesh
    WORLD NEUROSURGERY, 2024, 181 : E809 - E819
  • [25] Correlation Between Baseline Characteristics and Clinical Outcomes in a Large Population of Diabetes Patients Treated with Liraglutide in a Real-World Setting in Italy
    Lapolla, Annunziata
    Frison, Vera
    Bettio, Michela
    Dal Pos, Michela
    Rocchini, Paola
    Panebianco, Giuseppe
    Tadiotto, Federica
    Da Tos, Virgilio
    D'Ambrosio, Michele
    Marangoni, Alberto
    Ferrari, Maria
    Pianta, Alessandro
    Balzano, Sara
    Confortin, Loris
    Lamonica, Mario
    Mann, Narciso
    Strazzabosco, Marco
    Brun, Elisabetta
    Mesturino, Chiara Alberta
    Simoncini, Maria
    Zen, Francesco
    Box, Giuseppe
    Bonsembiante, Barbara
    Cardone, Claudio
    Dal Fra, Maria Grazia
    Gallo, Alessandra
    Masin, Michela
    Piarulli, Francesco
    Sartore, Giovanni
    Simioni, Natalino
    CLINICAL THERAPEUTICS, 2015, 37 (03) : 574 - 584
  • [26] Liraglutide 3.0mg (Saxenda©) for weight loss: a retrospective real-world clinical evaluation of effectiveness over 12 months among pre Bariatric Surgery patients
    Wilmington, Rebekah
    Ardavani, Arash
    Simenacz, Amelia
    Green, Carol
    Idris, Iskandar
    OBESITY SURGERY, 2023, 33 : S133 - S133
  • [27] Weight loss response in patients with obesity treated with injectable semaglutide in a real-world setting
    Khaled Alabduljabbar
    Moath Alsaqaaby
    Karl J. Neff
    Michael Crotty
    Carel W. le Roux
    Endocrine, 2024, 83 : 392 - 398
  • [28] How Effective Is Weight Loss by Oral Semaglutide on Glycemic Control in a Real-World Setting?
    Kesavadev, Jothydev
    Shankar, Arun
    Joshi, Shashank R.
    Ashik, Asha
    Yasmin, Shahana
    Basanth, Anjana
    Raj, Sourav K.
    Jothydev, Sunitha
    DIABETES, 2024, 73
  • [29] Weight loss response in patients with obesity treated with injectable semaglutide in a real-world setting
    Alabduljabbar, Khaled
    Alsaqaaby, Moath
    Neff, Karl J.
    Crotty, Michael
    le Roux, Carel W.
    ENDOCRINE, 2024, 83 (02) : 392 - 398
  • [30] Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review
    Amrita Ostawal
    Emina Mocevic
    Nana Kragh
    Weiwei Xu
    Diabetes Therapy, 2016, 7 : 411 - 438
12345